AXE 1.92% 26.5¢ archer materials limited

Ann: Biochip experiments begin to develop kidney disease testing, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,306 Posts.
    lightbulb Created with Sketch. 455
    im sure there are many questions and thoughts on this update. It all seems to be a very positive one and i liked reading that it is a significant milestone being that they are now testing for specific disease, and also that a challenge has been overcome with the degradation issue having been resolved. But my question is...why do we need to have kidney disease tested at such a fast rate on a chip without the results going to lab? surely this is one that the patient can wait a bit until the results come back from a lab? Where will this be of use? remote locations, underdeveloped countries?
 
watchlist Created with Sketch. Add AXE (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
0.005(1.92%)
Mkt cap ! $67.53M
Open High Low Value Volume
26.5¢ 27.0¢ 26.0¢ $29.40K 111.0K

Buyers (Bids)

No. Vol. Price($)
2 5962 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 40677 2
View Market Depth
Last trade - 15.25pm 05/11/2024 (20 minute delay) ?
AXE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.